Literature DB >> 9457145

Prognostic factors in Buprenorphine- versus methadone-maintained patients.

R S Schottenfeld1, J R Pakes, T R Kosten.   

Abstract

This study a) compared the effects of buprenorphine versus methadone maintenance on benzodiazepine and alcohol use and b) evaluated the prognostic significance of gender and psychopathology and their interaction with maintenance treatment. Eighty male and 36 female patients were randomly assigned to daily sublingual buprenorphine (4 or 12 mg) or oral methadone (20 or 65 mg). Maintenance medication was not associated with significant differences in alcohol or benzodiazepine use. Rates of abstinence from illicit opioids were significantly higher for females, within the buprenorphine 4-mg group, females also had significantly better retention, lower rates of opioid-positive urine samples, and higher rates of abstinence from illicit opioids. Lifetime sedative dependence was associated with significantly better retention, decreased rates of cocaine-positive urine samples, and increased rates of cocaine abstinence; among buprenorphine- but not methadone-maintained patients, it was also associated with increased rates of abstinence from illicit opioids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457145     DOI: 10.1097/00005053-199801000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  19 in total

1.  Gender differences in pharmacokinetics of maintenance dosed buprenorphine.

Authors:  David E Moody; Wenfang B Fang; Jerdravee Morrison; Elinore McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

Review 2.  Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Am J Addict       Date:  2019-05-26

3.  Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.

Authors:  Diane Warden; Geetha A Subramaniam; Thomas Carmody; George E Woody; Abu Minhajuddin; Sabrina A Poole; Jennifer Potter; Marc Fishman; Michael Bogenschutz; Ashwin Patkar; Madhukar H Trivedi
Journal:  Addict Behav       Date:  2012-05-08       Impact factor: 3.913

4.  Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.

Authors:  Chinazo O Cunningham; Angela Giovanniello; Hillary V Kunins; Robert J Roose; Aaron D Fox; Nancy L Sohler
Journal:  Am J Addict       Date:  2013 Jul-Aug

5.  Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories.

Authors:  Petra Jacobs; Alfonso Ang; Maureen P Hillhouse; Andrew J Saxon; Suzanne Nielsen; Paul G Wakim; Barbara E Mai; Larissa J Mooney; Jennifer S Potter; Jack D Blaine
Journal:  Am J Addict       Date:  2015-09-24

6.  Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.

Authors:  Annemarie Unger; Erika Jung; Bernadette Winklbaur; Gabriele Fischer
Journal:  J Addict Dis       Date:  2010-04

7.  Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.

Authors:  Amit Chakrabarti; George E Woody; Margaret L Griffin; Geetha Subramaniam; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2009-11-30       Impact factor: 4.492

8.  Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

Authors:  Jessica A Dreifuss; Margaret L Griffin; Katherine Frost; Garrett M Fitzmaurice; Jennifer Sharpe Potter; David A Fiellin; Jeffrey Selzer; Mary Hatch-Maillette; Susan C Sonne; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2013-01-18       Impact factor: 4.492

9.  Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis.

Authors:  Monica Bawor; Brittany B Dennis; Anuja Bhalerao; Carolyn Plater; Andrew Worster; Michael Varenbut; Jeff Daiter; David C Marsh; Dipika Desai; Meir Steiner; Rebecca Anglin; Guillaume Pare; Lehana Thabane; Zainab Samaan
Journal:  CMAJ Open       Date:  2015-07-17

Review 10.  Practical considerations for the clinical use of buprenorphine.

Authors:  Hendree E Jones
Journal:  Sci Pract Perspect       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.